Covered recipient · General Payments record
THOMAS Y CHOI
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018
$125.42
- Reported across 8 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2018 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $125.42 | 8 |
By paying entity
PY2018 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $39.68 | 2 |
| Allergan Inc. | $27.41 | 2 |
| PORTOLA PHARMACEUTICALS, INC. | $16.87 | 1 |
| Acerta Pharma LLC | $14.54 | 1 |
| GlaxoSmithKline, LLC. | $13.47 | 1 |
| Avanir Pharmaceuticals, Inc. | $13.45 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2018 | $125.42 | 8 |
Payment records · PY2018 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Allergan Inc. | $14.67 | 02/06/2018 | Food and Beverage | Undisputed | 01/23/2026 | 595579213 | CMS |
| Allergan Inc. | $12.74 | 04/24/2018 | Food and Beverage | Undisputed | 01/23/2026 | 595579223 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.54 | 04/04/2018 | Food and Beverage | Undisputed | 01/23/2026 | 562301763 | CMS |
| Avanir Pharmaceuticals, Inc. | $13.45 | 04/10/2018 | Food and Beverage | Undisputed | 01/23/2026 | 564980399 | CMS |
| GlaxoSmithKline, LLC. | $13.47 | 05/08/2018 | Food and Beverage | Undisputed | 01/23/2026 | 594651601 | CMS |
| PORTOLA PHARMACEUTICALS, INC. | $16.87 | 06/26/2018 | Food and Beverage | Undisputed | 01/23/2026 | 611098795 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16.09 | 04/10/2018 | Food and Beverage | Undisputed | 01/23/2026 | 589253395 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $23.59 | 07/30/2018 | Food and Beverage | Undisputed | 01/23/2026 | 589253399 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018
- Source files
- Dataset page · Bulk file · PY2018
- Generated from
- OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.